title: Bosentan for mild pulmonary vascular disease in ASD patients (the BOMPA trial): a double-blind, randomized controlled, pilot trial.
authors: Department of Cardiology, University Hospitals Leuven, Belgium.
authors: Alexander
authors: A
authors: Van De Bruaene
authors: Katrijn
authors: K
authors: Jansen
authors: Pieter
authors: P
authors: De Meester
authors: Marion
authors: M
authors: Delcroix
authors: Jens-Uwe
authors: JU
authors: Voigt
authors: Charlien
authors: C
authors: Gabriels
authors: Philip
authors: P
authors: Moons
authors: Werner
authors: W
authors: Budts
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000077300:Bosentan; D015331:Cohort Studies; D004311:Double-Blind Method; D005260:Female; D006344:Heart Septal Defects, Atrial / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011446:Prospective Studies; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan
keywords: Atrial septal defect; Bicycle stress echocardiography; Bosentan; Endothelin receptor antagonist; Pulmonary hypertension